20 units of semaglutide side effects Weight Loss Dosage Chart: Starting, Max, and Effective Doses Safety & Side Effects |

Table of Contents Understanding Wegovy Thigh Injections Wegovy (semaglutide 2.4 mg) is a once-weekly subcutaneous injection licensed by the MHRA for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Certain factors amplify vulnerability, and knowing which ones apply to you allows for targeted prevention rather than general worry

On average, patients experience: 5-10% weight loss within the first 3 months

Most people experience their first nausea within three to seven days of their initial semaglutide injection, with peak nausea typically arriving between days 10 and 21

PMID: 24461534

For example, Medicare and Medicaid may cover Mounjaro for type 2 diabetes, and in some cases, Zepbound for sleep apnea, but theyre less likely to cover Zepbound for weight loss